ASGN Incorporated logo ASGN - ASGN Incorporated

Inactive Ticker ASGN is not actively trading. Quotes and analytics may be stale.
Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 4
HOLD 5
SELL 4
STRONG
SELL
0
| PRICE TARGET: $34.75 DETAILS
HIGH: $38.00
LOW: $33.00
MEDIAN: $34.00
CONSENSUS: $34.75
UPSIDE: 65.79%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 50% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Undervalued Strong
Trading 70.9% below fair value
Current Price $20.96
Bear Case $65.29 211.5% upside ($65.29 - $20.96) / $20.96 = 211.5% 3% stage 1 growth, 11% discount
Fair Value $72.15 244.2% upside ($72.15 - $20.96) / $20.96 = 244.2% 4% stage 1 growth, 11% discount
Bull Case $81.06 286.8% upside ($81.06 - $20.96) / $20.96 = 286.8% 5% stage 1 growth, 11% discount

Adjust Assumptions

4.0%
11.0%
3.0%

Key Value Driver

FCF growth rate (4% base case)

Terminal Value % of EV 34%
Implied Market Multiple 6.6x
Market is pricing in (growth) -6.7% vs our 4.0% base

Plain-Language Summary

Using a two-stage FCF DCF with 4% growth decelerating over 15 years, discounted at 11%, the base-case intrinsic value is $72.15 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (13 analysts) $34.75
Analyst Range $33.00 – $38.00
Divergence from AlphaVal 108%

Warnings

Stock-based employee pay equals 42% of profits. This dilutes existing shareholders, so cash flow alone overstates what owners really earn.
Wall Street's average price target is $34.75 (from 13 analysts). Our estimate is 108% above the consensus -- consider that gap carefully.

Key Risks

  • P/E alone misleads — earnings depressed by growth investment
  • Cyclical or commodity businesses may be misclassified as platforms
  • Terminal value dominance suggests sensitivity to long-run assumptions